Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.
作者信息
Terpos E, Christoulas D, Kokkoris P, Anargyrou K, Gavriatopoulou M, Migkou M, Tsionos K, Dimopoulos M A
机构信息
Department of Clinical Therapeutics, University of Athens School of Medicine.
Department of Clinical Therapeutics, University of Athens School of Medicine.
出版信息
Ann Oncol. 2010 Jul;21(7):1561-1562. doi: 10.1093/annonc/mdq259. Epub 2010 May 23.
PMID:20497962
Abstract
摘要
Zotero 插件